Calledo, Asahel .
HRN: 22-61-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/24/2024
05/01/2024
ORAL
5ml
Q8
Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes